Global Paediatric Vaccine Market (2021 to 2026) – by Type, Technology, Application and Geography –

Global Paediatric Vaccine Market (2021 to 2026) – by Type, Technology, Application and Geography –

Global Paediatric Vaccine Market (2021 to 2026) – by Type, Technology, Application and Geography –

DUBLIN–(BUSINESS WIRE)–The “Global Paediatric Vaccine market (2021-2026) by Type, Technology, Application, Geography and the Impact of COVID-19 with Ansoff Analysis, Infogence Competitive Quadrant” report has been added to’s offering.

The global pediatric vaccines market is estimated to be USD 49.7 billion in 2021 and is expected to reach USD 82.35 billion by 2026, growing at a CAGR of 10.6%.

Early vaccination helps to develop antibodies against several infectious diseases. Vaccinations are prescribed in different age groups. Early immunization can prevent 2 million to 3 million deaths every year. Vaccine-preventable diseases are known to have a costly impact leading to frequent hospitalizations and death in certain cases. As per the UNICEF, an estimated 14 million infants have not received the vaccination, and around 85 countries are still to receive the Global Vaccination Action Plan (GVAP).

Pediatric vaccines are administered to an infant in its pediatric stage i.e. (0-12). These vaccines include the DTP vaccine, MMR vaccine, polio vaccine, and meningococcal vaccine, etc. They are usually administered at regular intervals to fight against infections and seasonal variations. In today’s dynamic business environment, there has been an excessive focus on R&D for the vaccines and the maximum coverage of the infant vaccines. With the increasing focus of the Government on vaccination, pediatric vaccines have increased over time. Besides, technologies such as synthetic vaccinology and platform manufacturing can help speed up the processing time taken to manufacture the new vaccines. This can additionally also help in improving the vaccination rate. Healthcare associations like the UNICEF or the WHO actively promote immunization campaigns, especially in developing countries.

Certain factors, such as the rising number of chronic diseases across the globe along with the global initiatives taken towards vaccine production for rare diseases, have been major drivers of growth for the pediatric market. Increasing cases of invasive cervical cancer are also expected to fuel the growth of the market. Such cancer types can be prevented through the HPV vaccine and regular cervical screenings between the ages of 9-12. Additionally, increasing awareness about the importance of pediatric vaccination in the prevention of diseases is expected to fuel market growth.

However, the costs attached to immunization and the accessibility restrains the growth of this market. The increasing availability of biosimilar at low rates is also creating hindrances for the market.

Market Dynamics


  • Rising Burden of Chronic Diseases
  • Technological Advancements in Vaccines
  • Favorable Government Support in Promoting Vaccination


  • Cost of Immunization
  • Low Medical Coverage and Healthcare Services in Low – and Middle-income Countries


  • Growing Importance and Awareness of Immunization
  • Rising Number of Collaborations, Expansions, and Mergers


  • Stringent Regulatory Compliance in the Development of Vaccines
  • Refusal of Immunization due to Low Awareness and Vaccines Shortages


  • The Emergence of a Paediatric Vaccine as a Therapeutic Agent Against Cervical Cancer

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Paediatric Vaccines Market.
  • The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of COVID-19 on the market is also featured in the report.
  • The report also contains the competitive analysis using the Competitive Quadrant, the analyst’s Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Companies Mentioned

  • GlaxoSmithKline PLC
  • Indian Immunologicals Limited
  • AstraZeneca
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Pfizer Inc.
  • Sanofi SA
  • Seqirus (CSL Limited)
  • Sinovac Biotech Ltd
  • Grifols
  • Serum Institute of India Pvt. Ltd.
  • Cadila Healthcare Ltd
  • Panacea Biotec
  • Daiichi Sankyo
  • Johnson & Johnson
  • Astellas Pharma
  • Bristol-Myers Squibb
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Abbott Laboratories

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900